Los Angeles BRI
Torrance, California, 90502, United States
NCT Number: NCT00733278
This is a pilot study of up to 10 women, which will test the hypothesis that the placement of copper IUDs through the uterine incision at the time of uncomplicated elective C-section is technically feasible and acceptable to women seeking long-term contraception.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Phase 4
Torrance, California, 90502, United States
Women will be enrolled in this study during late prenatal care. Consent for placement of the IUD will be verified prior to elective C-section. After removal of the placenta, the copper IUD will be placed through the incision at the fundus and the tail strings will be delivered through the cervix. Data will be collected about patient bleeding and possible infection during the immediate postoperative period. The visibility of the strings will be verified at discharge and at 2 and 6 weeks postpartum. Fundal placement of the IUD will be verified by ultrasound at the patient's last visit.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intraoperative placement of copper IUD at time of C-section
Other names: ParaGard Intrauterine Contraceptive Device
Time frame: 6 weeks
Time frame: At 3 days, 2 weeks and 6 weeks postpartum
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Other
Acceptability and Technical Feasibility of Insertion of a Copper IUD at Time of Elective C-section: A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06557499
Contraception
Berkeley, California, United States
View Trial DetailsNCT07326007
Contraception
Giza, Egypt
View Trial DetailsNCT05732142
Contraception, Gender Equity
La Jolla, California, United States
View Trial DetailsNCT03127722
Contraception
Chandler, Arizona, United States
View Trial Details